Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma

doi:10.3748/wjg.v21.i18.5591

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7526)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

352

WORD

263

HTML

4053

Figures (1-2)

125

Tables (1-4)

133

Sum=4926

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1028

Download

1572

Sum=2600

May 14, 2015 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. May 14, 2015; 21(18): 5591-5597
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5591

Open in New Tab Full Size Figure Download Figure

Figure 1 Survival curves for the complete cohort. A: Cancer-specific survival (CSS); B: Recurrence-free survival (RFS) curves for patients with esophageal squamous cell carcinoma according to preoperative serum neutrophil-lymphocyte ratio (NLR).

Open in New Tab Full Size Figure Download Figure

Figure 2 Survival curves for stage IIIA patients. A: Cancer-specific survival (CSS); B: Recurrence-free survival (RFS) curves according to preoperative serum neutrophil-lymphocyte ratio (NLR) for patients with pathological tumor-node-metastasis stage IIIA esophageal squamous cell carcinoma

Citation: Duan H, Zhang X, Wang FX, Cai MY, Ma GW, Yang H, Fu JH, Tan ZH, Meng YQ, Fu XY, Ma QL, Lin P. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. World J Gastroenterol 2015; 21(18): 5591-5597
URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5591.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5591